1. The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review
   Giuseppe Scaletta et al, 2017, Expert Review of Anticancer Therapy CrossRef
2. Prognostic value of serum HE4 in patients with advanced ovarian, fallopian tube, and peritoneal carcinoma
   Dong Mi et al, 2020, Archives of Gynecology and Obstetrics CrossRef
3. Role of Human Epididymis Protein 4 (HE4) in Determining Survival of Patients With Endometrial Cancer: A Meta-Analysis
   Ying He et al, 2020, Technology in Cancer Research & Treatment CrossRef
4. VCAM-1 complements CA-125 in detecting recurrent ovarian cancer
   Jin Song et al, 2023, Clinical Proteomics CrossRef
5. Electrochemical Impedance Spectroscopy Based Biosensors: Mechanistic Principles, Analytical Examples and Challenges towards Commercialization for Assays of Protein Cancer Biomarkers
   Tomas Bertok et al, 2019, ChemElectroChem CrossRef
6. Prospective study of the role of HE4 and CA125 in treatment and follow-up in ovarian cancer patients
   Ann-Lisbeth Liest MD et al, 2020, Obstetrics & Gynecology International Journal CrossRef
7. Fabrication of a Highly Sensitive Electrochemical Immunosensor for Human Epididymis Protein 4 (HE4) Detection
   Jian Qu et al, 2018, International Journal of Electrochemical Science CrossRef
8. Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study
   Francesco Plotti et al, 2021, Biomedicines CrossRef
9. Evaluation of HE4 and TTR for diagnosis of ovarian cancer: Comparison with CA-125
   Xin Zheng et al, 2018, Journal of Gynecology Obstetrics and Human Reproduction CrossRef
10. Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy
    Anita Chudecka-Głaz et al, 2023, Diagnostics CrossRef
11. Prognostic value of HE4 in patients with ovarian cancer
    Cunzhong Yuan et al, 2018, Clinical Chemistry and Laboratory Medicine (CCLM) CrossRef
12. Physiopathological factors affecting the diagnostic value of serum HE4-test for gynecologic malignancies
    Wanglei Qu et al, 2016, Expert Review of Molecular Diagnostics CrossRef
13. Serum human epididymis protein 4 vs. carbohydrate antigen 125 in ovarian cancer follow-up
    Simona Ferraro et al, 2018, Clinical Biochemistry CrossRef